(Q48553404)

12 February 2018

title

Circulating cytokines in Alzheimer's disease. (English)

1 reference

12 February 2018

0 references

Singh VK

1

1 reference

12 February 2018

Guthikonda P

series ordinal

2

1 reference

12 February 2018

publication date

1 November 1997

1 reference

12 February 2018

Journal of Psychiatric Research

published in

1 reference

12 February 2018

volume

31

1 reference

12 February 2018

issue

6

1 reference

12 February 2018

page(s)

657-660

1 reference

12 February 2018

Reduced natural killer cell activity in patients with dementia of the Alzheimer type.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

The participation of interleukin-6 in the pathogenesis of alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Serum interleukin-2 levels in patients with dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Interleukin-2 receptor in peripheral blood lymphocytes of Alzheimer's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Studies of neuroimmune markers in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Immune-activation model in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

Interleukin-12 and its role in the generation of TH1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2897%2900023-X

10.1016/S0022-3956(97)00023-X

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9447570

1 reference

12 February 2018